Global Prostaglandin Market Growth 2019-2024
Table of Contents
2019-2024 Global Prostaglandin Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Prostaglandin Consumption 2014-2024
- 2.1.2 Prostaglandin Consumption CAGR by Region
- 2.2 Prostaglandin Segment by Type
- 2.2.1 Human Prostaglandin
- 2.2.2 Veterinary Prostaglandin
- 2.3 Prostaglandin Consumption by Type
- 2.3.1 Global Prostaglandin Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Prostaglandin Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Prostaglandin Sale Price by Type (2014-2019)
- 2.4 Prostaglandin Segment by Application
- 2.4.1 Cardiovascular
- 2.4.2 Digestive
- 2.4.3 Gynecological and Obstetrical
- 2.4.4 Ophthalmologic
- 2.4.5 Other
- 2.5 Prostaglandin Consumption by Application
- 2.5.1 Global Prostaglandin Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Prostaglandin Value and Market Share by Application (2014-2019)
- 2.5.3 Global Prostaglandin Sale Price by Application (2014-2019)
3 Global Prostaglandin by Players
- 3.1 Global Prostaglandin Sales Market Share by Players
- 3.1.1 Global Prostaglandin Sales by Players (2017-2019)
- 3.1.2 Global Prostaglandin Sales Market Share by Players (2017-2019)
- 3.2 Global Prostaglandin Revenue Market Share by Players
- 3.2.1 Global Prostaglandin Revenue by Players (2017-2019)
- 3.2.2 Global Prostaglandin Revenue Market Share by Players (2017-2019)
- 3.3 Global Prostaglandin Sale Price by Players
- 3.4 Global Prostaglandin Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Prostaglandin Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Prostaglandin Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Prostaglandin by Regions
- 4.1 Prostaglandin by Regions
- 4.1.1 Global Prostaglandin Consumption by Regions
- 4.1.2 Global Prostaglandin Value by Regions
- 4.2 Americas Prostaglandin Consumption Growth
- 4.3 APAC Prostaglandin Consumption Growth
- 4.4 Europe Prostaglandin Consumption Growth
- 4.5 Middle East & Africa Prostaglandin Consumption Growth
5 Americas
- 5.1 Americas Prostaglandin Consumption by Countries
- 5.1.1 Americas Prostaglandin Consumption by Countries (2014-2019)
- 5.1.2 Americas Prostaglandin Value by Countries (2014-2019)
- 5.2 Americas Prostaglandin Consumption by Type
- 5.3 Americas Prostaglandin Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Prostaglandin Consumption by Countries
- 6.1.1 APAC Prostaglandin Consumption by Countries (2014-2019)
- 6.1.2 APAC Prostaglandin Value by Countries (2014-2019)
- 6.2 APAC Prostaglandin Consumption by Type
- 6.3 APAC Prostaglandin Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Prostaglandin by Countries
- 7.1.1 Europe Prostaglandin Consumption by Countries (2014-2019)
- 7.1.2 Europe Prostaglandin Value by Countries (2014-2019)
- 7.2 Europe Prostaglandin Consumption by Type
- 7.3 Europe Prostaglandin Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Prostaglandin by Countries
- 8.1.1 Middle East & Africa Prostaglandin Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Prostaglandin Value by Countries (2014-2019)
- 8.2 Middle East & Africa Prostaglandin Consumption by Type
- 8.3 Middle East & Africa Prostaglandin Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Prostaglandin Distributors
- 10.3 Prostaglandin Customer
11 Global Prostaglandin Market Forecast
- 11.1 Global Prostaglandin Consumption Forecast (2019-2024)
- 11.2 Global Prostaglandin Forecast by Regions
- 11.2.1 Global Prostaglandin Forecast by Regions (2019-2024)
- 11.2.2 Global Prostaglandin Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Prostaglandin Forecast by Type
- 11.8 Global Prostaglandin Forecast by Application
12 Key Players Analysis
- 12.1 CEPIA
- 12.1.1 Company Details
- 12.1.2 Prostaglandin Product Offered
- 12.1.3 CEPIA Prostaglandin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 CEPIA News
- 12.2 Johnson Matthey
- 12.2.1 Company Details
- 12.2.2 Prostaglandin Product Offered
- 12.2.3 Johnson Matthey Prostaglandin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Johnson Matthey News
- 12.3 Pfizer
- 12.3.1 Company Details
- 12.3.2 Prostaglandin Product Offered
- 12.3.3 Pfizer Prostaglandin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Pfizer News
- 12.4 Cayman Chemical
- 12.4.1 Company Details
- 12.4.2 Prostaglandin Product Offered
- 12.4.3 Cayman Chemical Prostaglandin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Cayman Chemical News
- 12.5 EMD Millipore
- 12.5.1 Company Details
- 12.5.2 Prostaglandin Product Offered
- 12.5.3 EMD Millipore Prostaglandin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 EMD Millipore News
- 12.6 Yonsung Fine Chemicals
- 12.6.1 Company Details
- 12.6.2 Prostaglandin Product Offered
- 12.6.3 Yonsung Fine Chemicals Prostaglandin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Yonsung Fine Chemicals News
- 12.7 Everlight Chemical
- 12.7.1 Company Details
- 12.7.2 Prostaglandin Product Offered
- 12.7.3 Everlight Chemical Prostaglandin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Everlight Chemical News
- 12.8 Piramal Enterprises
- 12.8.1 Company Details
- 12.8.2 Prostaglandin Product Offered
- 12.8.3 Piramal Enterprises Prostaglandin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Piramal Enterprises News
- 12.9 Bio-Techne Corporation
- 12.9.1 Company Details
- 12.9.2 Prostaglandin Product Offered
- 12.9.3 Bio-Techne Corporation Prostaglandin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Bio-Techne Corporation News
- 12.10 Mironova Labs
- 12.10.1 Company Details
- 12.10.2 Prostaglandin Product Offered
- 12.10.3 Mironova Labs Prostaglandin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Mironova Labs News
- 12.11 Chirogate
13 Research Findings and Conclusion
This report studies the Prostaglandin market. Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response.
Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
The global average price of Prostaglandin is in the decreasing trend, from 361.6 USD/Kg in 2012 to 331.1 USD/L in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Prostaglandin includes Human Prostaglandin and Veterinary Prostaglandin. The proportion of Human Prostaglandin in 2016 is about 82%, and the proportion is in decreasing trend from 2012 to 2016.
Prostaglandin is widely used in Cardiovascular, Digestive, Gynecological and Obstetrical, Ophthalmologic, etc. The most proportion of Prostaglandin is Cardiovascular, and the sales in 2016 is about 410 Kg.
According to this study, over the next five years the Prostaglandin market will register a 6.1% CAGR in terms of revenue, the global market size will reach US$ 660 million by 2024, from US$ 460 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Prostaglandin business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Prostaglandin market by product type, application, key manufacturers and key regions and countries.
This study considers the Prostaglandin value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Human Prostaglandin
Veterinary Prostaglandin
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Cardiovascular
Digestive
Gynecological and Obstetrical
Ophthalmologic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
CEPIA
Johnson Matthey
Pfizer
Cayman Chemical
EMD Millipore
Yonsung Fine Chemicals
Everlight Chemical
Piramal Enterprises
Bio-Techne Corporation
Mironova Labs
Chirogate
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Prostaglandin consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Prostaglandin market by identifying its various subsegments.
Focuses on the key global Prostaglandin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Prostaglandin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Prostaglandin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.